Literature DB >> 6105243

Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads.

B H Lauterburg, H F Taswell, A A Pineda, E R Dickson, E A Burgstaler, G L Carlson.   

Abstract

The accumulation of bile acids has been implicated in the pathogenesis of pruritus of cholestasis. To study the effect of bile-acid depletion on pruritus, 8 patients with chronic cholestasis and intractable pruritus which had not responded to cholestyramine and/or phenobarbitone underwent plasma perfusion through USP-charcoal-coated glass beads. DSuring twenty-two perfusions, between 957 and 6100 ml of plasma were perfused through charcoal columns, resulting in the removal of 126-795 mumol of bile acids. The mean extraction of the perfused bile acids was 81%. After the perfusions, all patients had prompt relief of their pruritus, lasting from 24 h to 5 months. Although the clinical effect may be due to the removal of unidentified pruritogens other than bile acids, charcoal plasma perfusion may improve the quality of life of incapacitated patients with servere intractable pruritus of cholestasis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6105243     DOI: 10.1016/s0140-6736(80)92938-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

1.  Pruritus.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-12

2.  Extracorporeal devices for treatment of refractory pruritus in cholestatic liver disease.

Authors:  Roger Williams
Journal:  Hepatol Int       Date:  2017-06-06       Impact factor: 6.047

Review 3.  Pruritus associated with cholestasis. A review of pathogenesis and management.

Authors:  M Khandelwal; P F Malet
Journal:  Dig Dis Sci       Date:  1994-01       Impact factor: 3.199

4.  Role of plasmapheresis in primary biliary cirrhosis.

Authors:  L B Cohen; E P Ambinder; A M Wolke; S P Field; F Schaffner
Journal:  Gut       Date:  1985-03       Impact factor: 23.059

5.  Treatment of pruritus of primary biliary cirrhosis with rifampin.

Authors:  A Podesta; P Lopez; R Terg; F Villamil; D Flores; R Mastai; C B Udaondo; J P Companc
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.